Hostname: page-component-6bf8c574d5-pdxrj Total loading time: 0 Render date: 2025-03-09T21:25:42.625Z Has data issue: false hasContentIssue false

Seminal contributions of Timothy J. Crow

Published online by Cambridge University Press:  07 March 2025

Lena Palaniyappan*
Affiliation:
Douglas Mental Health University Institute, Department of Psychiatry, McGill University, QC, Canada Department of Psychiatry, Schulich School of Medicine & Dentistry, University of Western Ontario London, ON, Canada Robarts Research Institute & Lawson Health Research Institute, London, ON, Canada
Peter F. Liddle
Affiliation:
Institute of Mental Health, University of Nottingham, Nottingham, UK
*
Corresponding author: Lena Palaniyappan; Email: lena.palaniyappan@mcgill.ca
Rights & Permissions [Opens in a new window]

Abstract

We recall the life and work of Timothy J. Crow, whose contributions provided great insights into the pathophysiology of schizophrenia and continue to shape many questions in the field. We compile his key works relating to psychotic disorders, focusing on the trajectory of his theoretical stance. Our account is interlaced with our own interpretation of the evidence that influenced Crow’s arguments over the years as well as his scientific method. Crow has had a significant impact on the neuroscience of schizophrenia. Many of his observations are still valid and several questions he raised remain unanswered to date.

Type
Personal Tribute
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Introduction

Crow’s contributions have profoundly shaped our pursuit of schizophrenia’s pathophysiology. He pioneered the first neuroimaging study revealing ventricular abnormalities, refined the notion of a continuum of psychosis, examined and dismissed the viral hypothesis of schizophrenia, and developed an early subtyping schema that preceded current investigations on the heterogeneity of schizophrenia. His work on genetics, cerebral asymmetry, and language, though unfinished in his lifetime, exemplifies his approach to the schizophrenia problem. Here, we trace his 5 major contributions in chronological order. We elucidate how a remarkable psychiatric scientist rigorously pursued clinical theory-building and testing at a time of rapid technological growth in neuroscience.

Dopamine hypothesis and the mechanism of action of antipsychotic medication

As a result of his pharmacological and behavioral studies of self-stimulation in rats, performed during his PhD, Crow played a cardinal role in establishing the role of dopamine in incentive motivation (Crow, Reference Crow1973). Subsequently, Seeman and colleagues (Seeman, Lee, Chau-Wong, & Wong, Reference Seeman, Lee, Chau-Wong and Wong1976) demonstrated that all effective antipsychotic drugs available at that time blocked dopamine receptors at concentrations that were correlated with their clinical potency, adding to the speculation that dopamine blockade was a crucial aspect of antipsychotic activity. Crow and his colleagues at Northwick Park Hospital (Johnstone, Crow, Frith, Carney, & Price, Reference Johnstone, Crow, Frith, Carney and Price1978), carried out a trial comparing the effects of the alpha isomer of flupentixol, which binds to dopamine receptors, with the effects of the beta isomer, which does not bind to that receptor despite sharing many of the other pharmacological actions of the alpha isomer. They demonstrated that the antipsychotic action of flupentixol is confined to the alpha-isomer. Furthermore, the therapeutic effects were largely confined to the positive symptoms: delusions, hallucinations, and formal thought disorder. For the subsequent four decades, the hypothesis of dopaminergic overactivity has played a major role in accounts of the neurochemistry of schizophrenia. Recent studies using Positron Emission Tomography indicate an excess of dopamine in presynaptic nerve terminals in schizophrenia, though a similar presynaptic dopamine excess is also observed in psychotic bipolar disorder (Jauhar et al., Reference Jauhar, Nour, Veronese, Rogdaki, Bonoldi, Azis and Howes2017) consistent with the evidence from the flupentixol study that dopamine blockade is effective against positive psychotic symptoms, rather than acting on the on a process that is central to the entire gamut of symptoms of schizophrenia.

Cognition and brain structure in schizophrenia

Crow was fascinated by the degree of cognitive impairment observed in cases of chronic schizophrenia, most notably the age disorientation exhibited by an appreciable proportion of long-stay patients who had a fixed belief that their age was only a few years greater than the age at the time of admission to hospital, despite the fact that this was in many cases several decades in the past (Crow and Mitchell, Reference Crow and Mitchell1975). Many cases exhibited impairment on the cognitive tests comparable to that observed in neurological cases with overt brain damage. The severity of the observed cognitive impairments led him to challenge the prevailing assumption that such impairments were not associated with overt brain damage. The development of computed tomography scanning in the mid-1970s provided the tool to address the issue. In the landmark paper (Johnstone, Crow, Frith, Husband, & Kreel, Reference Johnstone, Crow, Frith, Husband and Kreel1976), Crow and his colleagues at Northwick Park Hospital reported that in a sample of severely impaired long-stay patients from Shenley Hospital, the cerebral ventricles were enlarged relative to overall brain size. They reported that this group of severely impaired patients also exhibited marked cognitive impairments (including poor performance on serial sevens and delayed recall) that were significantly correlated with the degree of ventricular enlargement.

In the subsequent years, the findings of other investigators provided conflicting evidence regarding ventricular enlargement in schizophrenia. More recent meta-analysis confirms the early reports from Crow and colleagues, but the effect is smaller than initially reported (Sayo, Jennings, & Van Horn, Reference Sayo, Jennings and Van Horn2012). Numerous subsequent investigations have also confirmed impairment of many aspects of cognition in schizophrenia (McCutcheon, Keefe, & McGuire, Reference McCutcheon, Keefe and McGuire2023), with diverse associations between the cognitive impairments and abnormalities of brain structure and function in schizophrenia. In their review, McCutcheon et al. (Reference McCutcheon, Keefe and McGuire2023) propose that these abnormalities converge on a common mechanism entailing imbalanced interactions between excitatory and inhibitory (E/I) neurons of cortical microcircuits.

Positive and negative symptoms and subtypes of schizophrenia

The finding of the flupentixol study, together with the observation that abuse of amphetamine, a drug that promotes the release of dopamine from presynaptic terminals can produce an illness strongly resembling paranoid schizophrenia, added to the growing evidence that dopamine plays a crucial role in acute psychosis. However, other evidence, most notably the finding of cerebral ventricular enlargement and marked cognitive impairment in individuals experiencing severely disabling chronic schizophrenia (Johnstone et al., Reference Johnstone, Crow, Frith, Husband and Kreel1976), suggested to Crow that in least some cases, there is a fundamental deficit distinct from that pathophysiological process underlying acute schizophrenic disturbance (Crow, Reference Crow1980). In this groundbreaking paper, he proposed that two distinguishable pathological processes might occur in schizophrenia. The first (which he labeled the type I syndrome) is characterized by positive symptoms (delusions, hallucinations, and formal thought disorder) and is associated with abnormal dopaminergic transmission; the second (the type II syndrome) is characterized by negative symptoms (affective flattening and poverty of speech) not directly related to dopaminergic transmission but likely associated with intellectual impairment and structural brain changes.

Recent factor analyses of the symptoms of schizophrenia embracing a more diverse range of symptoms reveal at least five distinguishable symptom clusters (Shafer & Dazzi, Reference Shafer and Dazzi2019), likely reflecting five distinguishable pathological processes. With sophisticated molecular imaging approaches, evidence has accrued in favor of a subgroup with predominantly dopaminergic aberrations, though uncertainty around the longitudinal stability of this subgroup still remains (Howes, Bukala, Jauhar, & McCutcheon, Reference Howes, Bukala, Jauhar and McCutcheon2025). A more stable subgroup with structural changes (reduced cortical grey matter) has also been consistently observed, though its association with cognitive impairment and negative symptoms has been less remarkable (Liang et al., Reference Liang, Heinrichs, Liddle, Jeon, Théberge and Palaniyappan2024).

Crow’s concept of distinguishable pathological processes leading to distinct clusters of symptoms provided a fruitful foundation for subsequent investigations. However, in later years, Crow himself focused strongly on identifying a single pathological process at the heart of the illness, as we discuss below.

Viral transmission and continuum hypothesis

Preliminary evidence indicative of virus-like particles in the CSF of a minority of patients with schizophrenia (Crow et al., Reference Crow, Ferrier, Johnstone, Macmillan, Owens, Parry and Tyrrell1979; Tyrrell, Parry, Crow, Johnstone, & Ferrier, Reference Tyrrell, Parry, Crow, Johnstone and Ferrier1979) led Crow to speculate that schizophrenia was a viral illness. Subsequently, he observed that pairs of siblings concordant for schizophrenia had a similar age of onset, but not similar calendar time of onset (Crow, Reference Crow1984; Crow & Done, Reference Crow and Done1986). This lack of evidence for a contagion hypothesis or horizontal transmission between siblings led him to propose a “provirus” acquired either by prenatal infection or in the germ line from an affected parent, might be integrated into the genome leading to schizophrenia (Crow, Reference Crow1984). He speculated that this virus (possibly a retrovirus) might interact with a proto-oncogene (a gene that promotes cell growth) that normally induces asymmetrical brain growth and cerebral dominance. This proposed interaction between provirus and proto-oncogene would interfere with the development of normal laterality at a specific developmental stage, leading to disturbed asymmetry in schizophrenia, and consequent disturbance of the capacity for communication and social interaction.

Crow postulated that evolutionary pressures lead to a high degree of variability in the postulated interaction between the provirus and proto-oncogene (Crow, Reference Crow1987). He proposed that a spectrum of severity of the distributed interaction between the provirus and proto-oncogene might generate a continuum of severity of psychotic illness extending from unipolar through bipolar affective and schizoaffective disorder to schizophrenia.

“Psychosis is the price we pay for language”

This idea has remained one of Crow’s longest-held theories of the origin of the continuum of psychosis. The earliest mention of the relevance of language appeared in his works in 1984 in the context of viral theory. Discussing the postmortem findings of asymmetry in schizophrenia from the Runwell Hospital collection (see (Kasper et al., Reference Kasper, Taylor, Janz, Kasper, Maier, Williams and Crow2010) for more context) and left-lateralized increase in limbic dopamine (Reynolds, Reference Reynolds1983), Crow stated that hemispheric asymmetry “…is an unusual and specific evolutionary development, associated with interindividual communication” (Crow, Reference Crow1984. He developed this idea further in his later thesis on pseudoautosomal locus for schizophrenia genes (Crow, Reference Crow1988). Since then, in almost all of his subsequent papers, language assumed a central place in his arguments on the function of psychosis-related genetic changes (Crow, Reference Crow1995).

Besides the neuroanatomical feature of disrupted asymmetry in schizophrenia, Crow considered 2 epidemiological features as critical explananda for pathogenetic theories of schizophrenia (Crow, Reference Crow1997): (1) the nuclear syndrome of schizophrenia, defined by its “first rank” symptoms, is universally present in all populations, across time, with approximately the same incidence despite its reproductive disadvantage (2) females have consistently later onset of schizophrenia than males. From this, he deduced that the genetic factors of schizophrenia must be linked to a speciation event (“big-bang” (Crow, Reference Crow2008b)) that influenced hemispheric specialization and conferred a balancing advantage to human populations. This factor, he argued, resided in the homologous regions of X/Y chromosomes and related to a key function influenced by cerebral asymmetry, i.e., the faculty of language.

His views as to the exact genetic factor changed over time from viral progene to polymorphism, recombining to non-recombining regions of X/Y homologous class, and later to epigenetics (Crow, Reference Crow2010). Nonetheless, he was steadfast in the idea that schizophrenia results from an intrinsic genetic variation that determines our linguistic capacity. When arguing for the primacy of language in psychosis, Crow did not restrict himself to language-based cognitive tests or the measures of formal thought disorder (except in 2 of his works that were not pursued further (Ceccherini-Nelli & Crow, Reference Ceccherini-Nelli and Crow2003; Ceccherini-Nelli, Turpin-Crowther, & Crow, Reference Ceccherini-Nelli, Turpin-Crowther and Crow2007). Instead, he viewed all of schizophrenia’s major symptoms as disorders of language (Crow, Reference Crow2004a). To this, he repeatedly called upon de Saussure’s semiology, Buehler’s Sprachtheorie, and Chomsky’s universal grammar. He argued for a hemispheric separation of the signifier (the referring word) and the signified (meaning of the referent) with bidirectional access being required during a discourse. When hemispheric balance is disrupted, as in schizophrenia, the use of a specific class of words called indexicals (e.g. I and you) which have interchangeable referents, becomes deviant. This disrupts the syntax of universal grammar. Self-other confusion typical of Schneiderian first-rank symptoms ensues (Crow, Reference Crow1998).

Today, many observations that diminish the premises of Crow’s arguments on asymmetry and evolutionary theory around language have come forth. His claims on the universality of incidence rates of schizophrenia have been shown to be inaccurate (McGrath, Saha, Chant, & Welham, Reference McGrath, Saha, Chant and Welham2008). With respect to disrupted cerebral asymmetry, there is a lack of specificity to psychosis (Ocklenburg et al., Reference Ocklenburg, Mundorf, Gerrits, Karlsson, Papadatou-Pastou and Vingerhoets2024) and an absence of the sex effects that he anticipated (Schijven et al., Reference Schijven, Postema, Fukunaga, Matsumoto, Miura, de Zwarte and Francks2023). No clear signal for positive genetic selection or balancing advantage has emerged; in fact, more recent studies indicate negative selection pressures (Pardiñas et al., Reference Pardiñas, Holmans, Pocklington, Escott-Price, Ripke, Carrera and Walters2018). There has been a consistent failure to implicate X/Y loci in extensive genetic studies of schizophrenia (Trubetskoy et al., Reference Trubetskoy, Pardiñas, Qi, Panagiotaropoulou, Awasthi and Bigdeli2022); instead, genetic evolutionary markers associated with schizophrenia have been reported at other loci not foreseen by Crow (Sandroni & Chaumette, Reference Sandroni and Chaumette2025). Some observations are fatal to Crow’s assertions, but others call for new data (e.g. estimating the global incidence of linguistic dysfunction and Scheiderian symptoms in psychosis, epigenetic studies of sex chromosomes).

Crow’s approach to the schizophrenia question

Crow’s seminal works provide glimpses of his intellectual style and approach to psychiatric research (Table 1). He appreciated the necessity of having a guiding hypothesis that was parsimonious in its explanatory capacity (e.g. despite his initial proposal of subtypes, he continued to focus on a singular process that can explain the myriad of symptoms). Setting out to test such hypotheses, he followed a strong interdisciplinary approach. This pursuit was more than seeking collaborators from other fields of inquiry; he was thoroughly immersed in the relevant foundational arguments from the other disciplines that supported his parsimonious hypotheses. This depth of his scholarship, at times, led him to call for a revision of mainstream thought in other disciplines (e.g., his differences with Darwin’s and Chomsky’s notions of language evolution (Crow, Reference Crow2004b)). Some of these calls were in provocatively titled correspondences and reviews (e.g. see Crow, Reference Crow2004c). In the same inimitable style, he also engaged with contrasting views in the field (e.g. see (Crow, Reference Crow2008a) also see (Forti et al., Reference Forti, Marconi, Carra, Fraietta, Trotta, Bonomo and Murray2015) and the response (Crow, Reference Crow2015). Importantly, he was prepared to change his own views if evidence necessitated a revision (e.g. rejected the viral contagion hypothesis on the basis of age of onset studies in siblings (Crow, Reference Crow1984).

Table 1. Key aspects of Crow’s clinical academic approach

He considered reliable clinical assessments to be critical to make progress with schizophrenia research and viewed some of the discrepancies in the field to be a result of variations in the ascertainment of clinical features (e.g. his preference for simple, well-operationalized rating scales administered by clinically experienced investigators (Crow, Reference Crow1985).

To conclude, Crow not only raised key questions that continue to challenge contemporary psychiatric research but also left behind a unique and integrative scientific approach to understanding the biological complexity of psychosis. Despite the challenges faced by his theories, we expect his legacy to continue inspiring forthcoming inquiries in the neuroscience of schizophrenia.

Acknowledgments

The authors are grateful to Prof. John McGrath of the University of Queensland for helping them with their inquiries about the most recent epidemiology literature.

Funding statement

L. Palaniyappan’s research is supported by Monique H. Bourgeois Chair in Developmental Disorders and the Graham Boeckh Foundation. He received a salary award from the Fonds de recherche du Québec-Santé (FRQS). PFL currently receives no financial support for research.

Competing interest

LP reports personal fees from Janssen Canada, Otsuka Canada, SPMM Course Limited, UK, Canadian Psychiatric Association; book royalties from Oxford University Press; investigator-initiated educational grants from Janssen Canada, Otsuka Canada outside the submitted work. PFL reports book royalties from Gaskell Press.

References

Ceccherini-Nelli, A., & Crow, T. J. (2003). Disintegration of the components of language as the path to a revision of Bleuler’s and Schneider’s concepts of schizophrenia. Linguistic disturbances compared with first-rank symptoms in acute psychosis. The British Journal of Psychiatry: The Journal of Mental Science, 182, 233240. https://doi.org/10.1192/bjp.182.3.233CrossRefGoogle Scholar
Ceccherini-Nelli, A., Turpin-Crowther, K., & Crow, T. J. (2007). Schneider’s first rank symptoms and continuous performance disturbance as indices of dysconnectivity of left- and right-hemispheric components of language in schizophrenia. Schizophrenia Research, 90(1), 203213. https://doi.org/10.1016/j.schres.2006.09.017CrossRefGoogle ScholarPubMed
Crow, T. J. (1973). Catecholamine-containing neurones and electrical self-stimulation. 2. A theoretical interpretation and some psychiatric implications. Psychological Medicine, 3(1), 6673. https://doi.org/10.1017/s0033291700046353CrossRefGoogle ScholarPubMed
Crow, T. J. (1980). Molecular pathology of schizophrenia: More than one disease process? British Medical Journal, 280(6207), 6668.CrossRefGoogle ScholarPubMed
Crow, T. J. (1984). A re-evaluation of the viral hypothesis: Is psychosis the result of retroviral integration at a site close to the cerebral dominance gene? The British Journal of Psychiatry: The Journal of Mental Science, 145, 243253. https://doi.org/10.1192/bjp.145.3.243CrossRefGoogle Scholar
Crow, T. J. (1985). The two-syndrome concept: Origins and current status. Schizophrenia Bulletin, 11(3), 471488. https://doi.org/10.1093/schbul/11.3.471CrossRefGoogle ScholarPubMed
Crow, T. J. (1987). Psychosis as a continuum and the virogene concept. British Medical Bulletin, 43(3), 754767. https://doi.org/10.1093/oxfordjournals.bmb.a072213CrossRefGoogle ScholarPubMed
Crow, T. J. (1988). Sex chromosomes and psychosis. The case for a pseudoautosomal locus. The British Journal of Psychiatry: The Journal of Mental Science, 153, 675683. https://doi.org/10.1192/bjp.153.5.675CrossRefGoogle ScholarPubMed
Crow, T. J. (1995). A Darwinian approach to the origins of psychosis. The British Journal of Psychiatry, 167(1), 1225. https://doi.org/10.1192/bjp.167.1.12CrossRefGoogle Scholar
Crow, T. J. (1997). Is schizophrenia the price that Homo sapiens pays for language? Schizophrenia Research, 28(2–3), 127141. https://doi.org/10.1016/s0920-9964(97)00110-2CrossRefGoogle ScholarPubMed
Crow, T. J. (1998). Nuclear schizophrenic symptoms as a window on the relationship between thought and speech. British Journal of Psychiatry, 173(4), 303309. https://doi.org/10.1192/bjp.173.4.303CrossRefGoogle ScholarPubMed
Crow, T. J. (2004a). Auditory hallucinations as primary disorders of syntax: An evolutionary theory of the origins of language. Cognitive Neuropsychiatry. (world). https://doi.org/10.1080/13546800344000192CrossRefGoogle ScholarPubMed
Crow, T. J. (2004b). The Speciation of Modern Homo Sapiens. OUP/British Academy.CrossRefGoogle Scholar
Crow, T. J. (2004c). What Marian Annett can teach Noam Chomsky and could have taught Stephen Jay Gould if he’d had time to listen. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 40(1), 120134. https://doi.org/10.1016/S0010-9452(08)70926-2CrossRefGoogle Scholar
Crow, T. J. (2008a). The emperors of the schizophrenia polygene have no clothes. Psychological Medicine, 38(12), 16811685. https://doi.org/10.1017/S0033291708003395CrossRefGoogle ScholarPubMed
Crow, T. J. (2008b). The ʻbig bangʼ theory of the origin of psychosis and the faculty of language. Schizophrenia Research, 102(1), 3152. https://doi.org/10.1016/j.schres.2008.03.010CrossRefGoogle ScholarPubMed
Crow, T. J. (2010). The continuum of psychosis—1986–2010. Psychiatric Annals, 40(2), 115119. https://doi.org/10.3928/00485718-20100127-08CrossRefGoogle Scholar
Crow, T. J. (2015). Cannabis and psychosis. The Lancet Psychiatry, 2(5), 381382. https://doi.org/10.1016/S2215-0366(15)00167-4CrossRefGoogle ScholarPubMed
Crow, T. J., & Done, D. J. (1986). Age of onset of schizophrenia in siblings: A test of the contagion hypothesis. Psychiatry Research, 18(2), 107117. https://doi.org/10.1016/0165-1781(86)90023-5CrossRefGoogle ScholarPubMed
Crow, T. J., Ferrier, I. N., Johnstone, E. C., Macmillan, J. F., Owens, D. G., Parry, R. P., & Tyrrell, D. A. (1979). Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid. Lancet (London, England), 1(8121), 842844. https://doi.org/10.1016/s0140-6736(79)91262-5CrossRefGoogle ScholarPubMed
Crow, T. J., & Mitchell, W. S. (1975). Subjective age in chronic schizophrenia: Evidence for a sub-group of patients with defective learning capacity? The British Journal of Psychiatry: The Journal of Mental Science, 126, 360363. https://doi.org/10.1192/bjp.126.4.360CrossRefGoogle ScholarPubMed
Forti, M. D., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., … Murray, R. M. (2015). Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. The Lancet Psychiatry, 2(3), 233238. https://doi.org/10.1016/S2215-0366(14)00117-5CrossRefGoogle ScholarPubMed
Howes, O. D., Bukala, B. R., Jauhar, S., & McCutcheon, R. A. (2025). The hypothesis of biologically based subtypes of schizophrenia: A 10-year update. World Psychiatry, 24(1), 4647. https://doi.org/10.1002/wps.21265CrossRefGoogle ScholarPubMed
Jauhar, S., Nour, M. M., Veronese, M., Rogdaki, M., Bonoldi, I., Azis, M., … Howes, O. D. (2017). A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia. JAMA Psychiatry, 74(12), 12061213. https://doi.org/10.1001/jamapsychiatry.2017.2943CrossRefGoogle Scholar
Johnstone, E. C., Crow, T. J., Frith, C. D., Carney, M. W., & Price, J. S. (1978). Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet (London, England), 1(8069), 848851. https://doi.org/10.1016/s0140-6736(78)90193-9CrossRefGoogle ScholarPubMed
Johnstone, E. C., Crow, T. J., Frith, C. D., Husband, J., & Kreel, L. (1976). Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (London, England), 2(7992), 924926. https://doi.org/10.1016/s0140-6736(76)90890-4CrossRefGoogle ScholarPubMed
Kasper, B. S., Taylor, D. C., Janz, D., Kasper, E. M., Maier, M., Williams, M. R., & Crow, T. J. (2010). Neuropathology of epilepsy and psychosis: The contributions of J.A.N Corsellis. Brain, 133(12), 37953805. https://doi.org/10.1093/brain/awq235CrossRefGoogle ScholarPubMed
Liang, L., Heinrichs, R. W., Liddle, P. F., Jeon, P., Théberge, J., & Palaniyappan, L. (2024). Cortical impoverishment in a stable subgroup of schizophrenia: Validation across various stages of psychosis. Schizophrenia Research, 264, 567577. https://doi.org/10.1016/j.schres.2022.05.013CrossRefGoogle Scholar
McCutcheon, R. A., Keefe, R. S. E., & McGuire, P. K. (2023). Cognitive impairment in schizophrenia: Aetiology, pathophysiology, and treatment. Molecular Psychiatry, 28(5), 19021918. https://doi.org/10.1038/s41380-023-01949-9CrossRefGoogle Scholar
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008). Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiologic Reviews, 30, 6776. https://doi.org/10.1093/epirev/mxn001CrossRefGoogle ScholarPubMed
Ocklenburg, S., Mundorf, A., Gerrits, R., Karlsson, E. M., Papadatou-Pastou, M., & Vingerhoets, G. (2024). Clinical implications of brain asymmetries. Nature Reviews Neurology, 20(7), 383394. https://doi.org/10.1038/s41582-024-00974-8CrossRefGoogle ScholarPubMed
Pardiñas, A. F., Holmans, P., Pocklington, A. J., Escott-Price, V., Ripke, S., Carrera, N., … Walters, J. T. R. (2018). Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nature Genetics, 50(3), 381389. https://doi.org/10.1038/s41588-018-0059-2CrossRefGoogle ScholarPubMed
Reynolds, G. P. (1983). Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature, 305(5934), 527529. https://doi.org/10.1038/305527a0CrossRefGoogle ScholarPubMed
Sandroni, V., & Chaumette, B. (2025). Understanding the Emergence of Schizophrenia in the Light of Human Evolution: New Perspectives in Genetics. Genes, Brain and Behavior, 24(1), e70013. https://doi.org/10.1111/gbb.70013CrossRefGoogle ScholarPubMed
Sayo, A., Jennings, R. G., & Van Horn, J. D. (2012). Study factors influencing ventricular enlargement in schizophrenia: A 20 year follow-up meta-analysis. NeuroImage, 59(1), 154167. https://doi.org/10.1016/j.neuroimage.2011.07.011CrossRefGoogle ScholarPubMed
Schijven, D., Postema, M. C., Fukunaga, M., Matsumoto, J., Miura, K., de Zwarte, S. M. C., … Francks, C. (2023). Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium. Proceedings of the National Academy of Sciences, 120(14), e2213880120. https://doi.org/10.1073/pnas.2213880120CrossRefGoogle ScholarPubMed
Seeman, P., Lee, T., Chau-Wong, M., & Wong, K. (1976). Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261(5562), 717719. https://doi.org/10.1038/261717a0CrossRefGoogle ScholarPubMed
Shafer, A., & Dazzi, F. (2019). Meta-analysis of the positive and Negative Syndrome Scale (PANSS) factor structure. Journal of Psychiatric Research, 115, 113120. https://doi.org/10.1016/j.jpsychires.2019.05.008CrossRefGoogle ScholarPubMed
Trubetskoy, V., Pardiñas, A. F., Qi, T., Panagiotaropoulou, G., Awasthi, S., Bigdeli, T. B., … Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2022). Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature, 604(7906), 502508. https://doi.org/10.1038/s41586-022-04434-5CrossRefGoogle ScholarPubMed
Tyrrell, D. A., Parry, R. P., Crow, T. J., Johnstone, E., & Ferrier, I. N. (1979). Possible virus in schizophrenia and some neurological disorders. Lancet (London, England), 1(8121), 839841. https://doi.org/10.1016/s0140-6736(79)91261-3CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Key aspects of Crow’s clinical academic approach